Clinical Trial

Effect of iTBS on Children With ADHD

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2023 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Attention Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder characterized by persistent symptoms of attention deficit and/or hyperactivity/impulsivity . Currently, the first line drugs for treating ADHD are central stimulants such as Tomoxetine and Guanfaxine. However, there is a risk of drug abuse and misuse, which often affects sleep and appetite, only 50% of patients can fully tolerate. This project uses the iTBS stimulation on weekends, children with ADHD finish scale evaluation, magnetic resonance imaging analysis, and cognitive function before and after stimulation, This study explores its therapeutic effect on attention deficit in children and adolescents with ADHD.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06010966
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions ADHD, rTMS
Enrollment 54 participants
Start Date 2023-09-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2023-12-13